Cspc Pharmaceutical | 1093 - Umsatzkosten

Aktienkurs
7.39
Täglich Wechseln
-0.06 -0.81%
Monatlich
-17.61%
Jährlich
13.34%
Q2 Prognose
7.62




Umsatzkosten Veränderung Datum
Akebia Therapeutics USD 10.34M 441K 2025-12
Alaunos Therapeutics USD 0 18K 2024-09
Avita Medical AUD 3.3M 166K 2025-12
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Ionis Pharmaceuticals USD 3M 5M 2026-03
IQVIA Holdings USD 3.08B 161M 2026-03
Jiangsu Hengrui CNY 1.09B 76.27M 2026-03
Kangmei Pharma CNY 1.11B 84.66M 2025-09
Moderna USD 955M 503M 2026-03
Organon & Co USD 766M 21M 2025-12
Revvity USD 323.46M 26.93M 2026-03
Sh Fosun Pharma CNY 5.07B 507.9M 2026-03
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Viatris USD 2.36B 195.9M 2026-03
Wuxi Apptec CNY 6.17B 95.51M 2026-03
Xeris Pharmaceuticals USD 13.66M 49K 2025-12
Zz Pientze Pharmaceu CNY 1.58B 245.15M 2026-03